Detalhe da pesquisa
1.
Radiation enhancement using focussed ultrasound-stimulated microbubbles for head and neck cancer: A phase 1 clinical trial.
Radiother Oncol;
198: 110380, 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38879128
2.
Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: A Phase 1 clinical trial.
PLoS Med;
21(5): e1004408, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758967
3.
Quantitative US Delta Radiomics to Predict Radiation Response in Individuals with Head and Neck Squamous Cell Carcinoma.
Radiol Imaging Cancer;
6(2): e230029, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38391311
4.
Quantitative Ultrasound for Evaluation of Tumour Response to Ultrasound-Microbubbles and Hyperthermia.
Technol Cancer Res Treat;
22: 15330338231200993, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37750232
5.
Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer.
Sci Rep;
13(1): 13566, 2023 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37604988
6.
Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasound.
Oncotarget;
12(25): 2437-2448, 2021 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34917262
7.
Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma.
Clin Transl Radiat Oncol;
28: 62-70, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33778174
8.
Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics.
Sci Rep;
11(1): 6117, 2021 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731738
9.
Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy.
Cancer Med;
10(8): 2579-2589, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314716
10.
Quantitative ultrasound radiomics using texture derivatives in prediction of treatment response to neo-adjuvant chemotherapy for locally advanced breast cancer.
Oncotarget;
11(42): 3782-3792, 2020 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33144919